Navigation Links
Cambrex Reports Fourth Quarter And Full Year 2012 Financial Results
Date:2/6/2013

– Continuing Operations," including the Company's expectation that full year 2013 sales, excluding the impact of foreign currency, will increase between 8% and 12% versus 2012, that full year 2013 EBITDA will be between $62 and $68 million, that capital expenditures will be approximately $36 to $40 million and that depreciation will be $22 to $24 million in 2013.  These and other forward looking statements may be identified by the fact that they use words such as "expects," "anticipates," "intends," "estimates," "believes" or similar expressions.  Any forward-looking statements contained herein are based on current plans and expectations and involve risks and uncertainties that could cause actual outcomes and results to differ materially from current expectations.  The factors described in Item 1A of Part I of the Company's Annual Report on Form 10-K for the period ended December 31, 2011, captioned "Risk Factors," or otherwise described in the Company's filings with the SEC, as well as any cautionary language in the Company's Annual Report on Form 10-K for the period ended December 31, 2011, provide examples of such risks and uncertainties that may cause the Company's actual results to differ materially from the expectations the Company describes in its forward-looking statements, including, but not limited to, pharmaceutical outsourcing trends, competitive pricing or product developments, governmental legislation and regulations (particularly environmental issues), tax rate, interest rate, technology, manufacturing and legal issues, including the outcome of outstanding litigation disclosed in the Company's public filings, changes in foreign exchange rates, uncollectible receivables, loss on disposition of assets, cancellations or delays in renewal of contracts, lack of suitable raw materials or packaging materials, and the Company's ability to receive regulatory approvals for its products, as well as risks relating to a Phase 3 supply agreeme
'/>"/>
SOURCE Cambrex Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Cambrex Reports First Quarter 2012 Results
2. Cambrex To Present At Jefferies 2012 Global Healthcare Conference
3. Cambrex Announces Significant New Supply Agreement
4. Cambrex to Announce Third Quarter 2012 Financial Results on October 31, 2012
5. Cambrex Reports Third Quarter 2012 Financial Results
6. Cambrex To Announce Fourth Quarter 2012 Financial Results On February 6, 2013
7. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
8. Sigma-Aldrich (NASDAQ: SIAL) Reports Q1 2012 Diluted EPS of $0.96, With Diluted Adjusted EPS of $0.99. Sales Increase 5% for Q1 2012. Full Year 2012 Diluted Adjusted EPS Outlook of $3.90 to $4.05 Reaffirmed.
9. Kelyniam Global Inc. Reports Record Cranial Implant Revenues in the 1st Quarter of 2012
10. Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2012
11. Mylan Reports Q1 2012 Adjusted Diluted EPS of $0.52, an 18% Increase Over Prior Year Quarter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... March 26, 2015 When they began ... existing PACS vendor their system would no longer ... they needed a better structured solution to support ... interWORKS due to its interface capabilities and its ... standards through to the hospital,s radiology department. Avreo,s ...
(Date:3/26/2015)... 2015  CCS Medical ("CCS"), one of the ... patients with chronic conditions, has named Rodney ... effective March 23.  Mr. Carson joins CCS from ... was President of Operations. Prior ... Vice President of Operations at NationsHealth, (n/k/a Convey ...
(Date:3/26/2015)... VEGAS , March 26, 2015 Zimmer ... Vivacit-E ® Advanced Bearing Technology with ... A paper published earlier this month reported that, ... Vivacit-E Advanced Bearing Technology featuring Vitamin E ... maintained a significant wear rate reduction of 95 percent, ...
Breaking Medicine Technology:Clinch Memorial Hospital Modernizes Workflow with Avreo interWORKS 2CCS Medical Team Hires Industry Operator Rodney Carson as CEO 2Zimmer Announces New Testing Milestone For Vitamin E Advanced Bearing Technology 2Zimmer Announces New Testing Milestone For Vitamin E Advanced Bearing Technology 3
... , BILLERICA, Mass., Dec. 4 Axsun Technologies, ... ), today announced the initial development and successful testing of ... Axsun believes this proprietary optical engine design raises the bar ... for swept source OCT light sources. This approach to ...
... , MORRISTOWN, N.J., Dec. 4 Watson ... specialty pharmaceutical company, today confirmed that its subsidiary, Watson Laboratories, ... U.S. Food and Drug Administration seeking approval to market its ... owned by Takeda Pharmaceutical Company Limited. Watson,s 8mg ramelteon ...
Cached Medicine Technology:Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 2Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 3Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 4Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 5Watson Files FDA Application for Generic Rozerem(R) 2Watson Files FDA Application for Generic Rozerem(R) 3
(Date:3/27/2015)... 2015 GenSight, the leading Enterprise Portfolio ... Fitzgerald, a former technology and financial executive to serve ... Chief Financial Officer. , Mr Fitzgerald was most recently ... backed by Amazon founder and CEO Jeff Bezos, Google ... to EverFi, he was a Senior Vice President at ...
(Date:3/27/2015)... (PRWEB) March 27, 2015 Operatic contenders ... of greatness on April 17th. The universally acclaimed baritone ... the 9th annual Opera Idol at The Merion in ... competition, which has drawn aspiring opera singers from around ... showcases some of the finest young talent in the ...
(Date:3/27/2015)... (PRWEB) March 27, 2015 Since September 2014, ... in his comeback tour after having been in retirement for ... eager for the performer to return to touring, and concert ... tickets for Omaha will likely sell out for the two ... BuyCheapTicketsToEvents.com to view the inventory of discounted Garth ...
(Date:3/27/2015)... 2015 “ VXi BlueParott Reveal ” ... Tech Report, which features the latest and coolest technology ... and special reporter for NewsWatch, conducted the review and ... headset, eliminating 90% of ambient noise. , Today, business ... emails are important to any professional, voice calls are ...
(Date:3/26/2015)... TX (PRWEB) March 27, 2015 Moreno ... proud to announce prestigious victories at the 2015 International ... ranch was quite successful across many categories of show ... our performance at the ABBA International Brahman show,” explained ... friendly competition, and the proof of our superior genetics ...
Breaking Medicine News(10 mins):Health News:GenSight Appoints Former Technology Executive as Chief Operating Officer 2Health News:Opera Idol Competition At The Merion In Evanston 2Health News:Garth Brooks Tickets for Omaha: BuyCheapTicketsToEvents.com Draws Customers by Discounting Prices on 2015 Tickets for Garth Brooks’ Tour Stops at CenturyLink Center 2Health News:A Device to Tune out Background Noise was Recently Featured on NewsWatch Television 2Health News:Red and Gray Brahman Cattle Champions Announced by Moreno Ranches at International Brahman Show and Sale in Houston, Texas 2
... Michael O'Donovan at Cardiff University// have discovered the gene which ... An analysis of 300 families where at least one ... The gene has been called "KIAA0319". ,"This is ... gene which contributes to susceptibility to the common form of ...
... the liver and can cause complications such as liver ... B vaccine is recommended for infants. Previous research has ... for up to 10 years. However, a recent study ... ,Researchers followed eight-hundred-and-forty-one Alaska natives vaccinated with three ...
... by researchers, brain stimulation may help depressive patients, when ... result on them. ,People suffering from sustained ... stimulation of their brains, when other medication were not ... brain associated with depressive feelings have shown a noticeable ...
... to children suffering from attention deficit hyperactivity disorder (ADHD), had ... the drug Ritalin, in the past, had been linked to ... time any study links the drug to cancer proneness in ... of Preventive Medicine and Community Health, The University of Texas, ...
... latest issue of Harvard Heart Letter, testing of eyes may ... of eye can predict the condition of the heart, kidneys ... study headed by Dr. John I. Loewenstein, a retina specialist ... been drawn between changing conditions of blood vessels inside the ...
... of the American Academy of Orthopedic Surgeons in Washington, D.C. ... the result of several problems other than anatomical, and not ... a surgery. The study that had observed about 6000 surgical ... said that patients who had other health troubles than back ...
Cached Medicine News:
... The first instrumentation ... efficiently manage the ... Proven technology automatically ... collates cassettes sequentially. ...
Shandon MicroWriter™ I Cassette Labeler is a permanent cassette marking system....
Fully modular system for long-term storage. Available as complete five-drawer system or as individual components....
Space-saving storage cabinets for microscope slides....
Medicine Products: